Cargando…
Phloretin Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Regulating the Inflammatory Response, Oxidative Stress and Apoptosis
The inflammatory process is proposed to be one of the factors to benign prostatic enlargement (BPH), and this is the first study examining the anti-inflammatory ability of phloretin in treating rats with testosterone-induced BPH. BPH would be induced by testosterone (10 mg/kg/day testosterone subcut...
Autores principales: | Hsu, Chao Yu, Lin, Yi Sheng, Weng, Wei Chun, Panny, Lauren, Chen, Hsiang Lai, Tung, Min Che, Ou, Yen Chuan, Lin, Chi Chien, Yang, Che Hsueh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399389/ https://www.ncbi.nlm.nih.gov/pubmed/34440487 http://dx.doi.org/10.3390/life11080743 |
Ejemplares similares
-
Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review
por: Yang, Che-Hsueh, et al.
Publicado: (2022) -
Incidental Prostate Cancer from Prostate with Benign Biopsies: A Predictive and Survival Analysis from Cohort Study
por: Yang, Che Hsueh, et al.
Publicado: (2022) -
Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
por: Shabani, Ehsan, et al.
Publicado: (2021) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Cleistanthins A and B Ameliorate Testosterone-Induced Benign Prostatic Hyperplasia in Castrated Rats by Regulating Apoptosis and Cell Differentiation
por: S C, Santosh Kumar, et al.
Publicado: (2022)